Table of Content




1. Executive Summary


2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
3.3.1: Blood Pressure Monitoring Devices
3.3.2: Pulmonary Pressure Monitoring Devices
3.3.3: Intracranial Pressure Monitoring Devices

3.4: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
3.4.1: Autologous Stem Cells
3.4.2: Autologous Non-Stem Cells

3.5: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
3.5.1: Neurodegenerative Disorders
3.5.2: Autoimmune Diseases
3.5.3: Cancer & Tumors
3.5.4: Cardiovascular Diseases


3.6: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
3.6.1: Hospitals
3.6.2: Ambulatory Surgical Centers
3.6.3: Others



4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region
4.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market

4.2.1: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
4.2.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others

4.3: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market

4.3.1: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
4.3.2: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others

4.4: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market

4.4.1: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
4.4.2: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others

4.5: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market

4.5.1: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
4.5.2: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
6.1.2: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
6.1.3: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
6.1.4: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
6.1.5: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region

6.2: Emerging Trends in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: BrainStorm Cell
7.2: Cytori Therapeutics
7.3: Dendreon Pharmaceuticals
7.4: Novartis
7.5: U.S. Stem Cell